Clopidogrel Market Will Target Emerging Markets by 2025
The substantial and high-level evidence gathered over the years support the use of Clopidogrel for reduction of mortality and morbidity patients with acute coronary syndrome, myocardial infarction, and a number of other indications.
View full press release